Beverly Green, MD, MPH, is a physician-scientist known for pioneering work in preventive and evidence-based medicine. With a goal of improving systems of care, she designs and evaluates programs that make effective treatment easier for patients to follow—and easier for providers to deliver.
Dr. Green’s research has a strong public health focus, targeting conditions that affect large proportions of the population, such as cardiovascular disease, cancer, and obesity. She also emphasizes leveraging technologies and systems-based care.
In 2016 Dr. Green launched the BP-CHECK study, which aims to find the easiest, most accurate way to diagnose high blood pressure. With a $2.8 million award from the Patient-Centered Outcomes Research Institute (PCORI), the study will compare blood pressure readings taken in clinic, at home, and at validated blood pressure kiosks to the 24-hour blood pressure test that is currently considered the gold standard for diagnosing hypertension.
Dr. Green’s previous research has shown that:
She is now working to translate similar innovative approaches to care into community settings through collaborations with the OCHIN Practice-Based Research Network and two large health insurance plans that provide Medicaid insurance to low-income individuals and families.
She is also a core member of the Alliance for Reducing Cancer, Northwest, a collaborative team of cancer prevention and control experts and community stakeholders whose mission is build relationships between researchers and community partners, conduct cancer-related research, and translate research into community practice.
Dr. Green was honored by Kaiser Permanente Washington in 1999 for her contributions to clinical quality improvement and was a finalist for the organization's 2004 Lifetime Achievement Award. She was as an associate editor for the American Journal of Preventive Medicine from 2009 to 2014. She is an editorial board member of the Journal of the American Board of Family Practice. She is also a fellow of the American Heart Association, an honor given for contributions to the field. Dr. Green has served as an associate clinical professor at the UW School of Medicine since 1992.
Margolis KL, Bergdall AR, Crain AL, JaKa MM, Anderson JP, Solberg LI, Sperl-Hillen J, Beran M, Green BB, Haugen P, Norton CK, Kodet AJ, Sharma R, Appana D, Trower NK, Pawloski PA, Rehrauer DJ, Simmons ML, McKinney ZJ, Kottke TE, Ziegenfuss JY, Williams RA, O'Connor PJ. Comparing pharmacist-led telehealth care and clinic-based care for uncontrolled high blood pressure: The hyperlink 3 pragmatic cluster-randomized trial. Hypertension. 2022 Oct 25. doi: 10.1161/HYPERTENSIONAHA.122.19816. Online ahead of print. PubMed
Dalmat RR, Ziebell RA, Kamineni A, Phipps AI, Weiss NS, Breslau ES, Corley DA, Green BB, Halm EA, Levin TR, Schottinger JE, Chubak J. Risk of colorectal cancer and colorectal cancer mortality beginning ten years after a negative colonoscopy, among screen-eligible adults 76-85 years old. Cancer Epidemiol Biomarkers Prev. 2022 Sep 13:EPI-22-0581. doi: 10.1158/1055-9965.EPI-22-0581. [Epub ahead of print]. PubMed
JaKa M, Bergdall A, Beran MS, Solberg L, Green BB, Andersen J, Kodet A, Norman S, Haugen P, Crain L, Trower N, Sharma R, Rehrauer D, Maeztu C, Margolis K. Reach in a pragmatic hypertension trial: A critical RE-AIM component. Contemp Clin Trials. 2022 Oct;121:106896. doi: 10.1016/j.cct.2022.106896. Epub 2022 Aug 24. PubMed
Margolis KL, Crain AL, Green BB, O'Connor PJ, Solberg LI, Beran M, Bergdall AR, Pawloski PA, Ziegenfuss JY, JaKa MM, Appana D, Sharma R, Kodet AJ, Trower NK, Rehrauer DJ, McKinney Z, Norton CK, Haugen P, Anderson JP, Crabtree BF, Norman SK, Sperl-Hillen JM. Comparison of explanatory and pragmatic design choices in a cluster-randomized hypertension trial: effects on enrollment, participant characteristics, and adherence. Trials. 2022 Aug 17;23(1):673. doi: 10.1186/s13063-022-06611-3. PubMed
Kottke TE, Anderson JP, Zillhardt JD, Sperl-Hillen JM, O'Connor PJ, Green BB, Williams RA, Averbeck BM, Stiffman MN, Beran M, Rakotz M, Margolis KL. Association of an automated blood pressure measurement quality improvement program with terminal digit preference and recorded mean blood pressure in 11 clinics. JAMA Netw Open. 2022;5(8):e2229098. doi: 10.1001/jamanetworkopen.2022.29098. PubMed
How KPWHRI is contributing to better cancer screening and better outcomes for patients.
Research on at-home testing for HPV could improve cancer prevention and ease screening for patients.
Beverly Green, MD, and Kaiser Permanente work to improve hypertension care.
VeryWell Health, March 16, 2022